Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
63.6M
-
Shares change
-
+62.5M
-
Total reported value, excl. options
-
$202M
-
Value change
-
+$198M
-
Number of buys
-
35
-
Price
-
$3.17
Significant Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q4 2021
37 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.6M shares
of 176M outstanding shares and own 36.04% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (21.6M shares), FMR LLC (6.87M shares), Rock Springs Capital Management LP (5.33M shares), Foresite Capital Management V, LLC (4.4M shares), Consonance Capital Management LP (3.5M shares), CHI Advisors LLC (3.02M shares), Avidity Partners Management LP (2M shares), Monashee Investment Management LLC (2M shares), Vivo Capital, LLC (2M shares), and RA CAPITAL MANAGEMENT, L.P. (1.85M shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.